Icl Israel Chemicals Stock Current Valuation
| ICL Stock | ILA 1,689 46.00 2.80% |
Valuation analysis of ICL Israel Chemicals helps investors to measure ICL Israel's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that ICL Israel's price fluctuation is very steady at this time. Calculation of the real value of ICL Israel Chemicals is based on 3 months time horizon. Increasing ICL Israel's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ICL Israel is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ICL Stock. However, ICL Israel's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1689.0 | Real 1628.5 | Hype 1689.0 | Naive 1619.28 |
The real value of ICL Stock, also known as its intrinsic value, is the underlying worth of ICL Israel Chemicals Company, which is reflected in its stock price. It is based on ICL Israel's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ICL Israel's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ICL Israel Chemicals helps investors to forecast how ICL stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ICL Israel more accurately as focusing exclusively on ICL Israel's fundamentals will not take into account other important factors: ICL Israel Chemicals Company Current Valuation Analysis
ICL Israel's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current ICL Israel Current Valuation | 43.75 B |
Most of ICL Israel's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ICL Israel Chemicals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, ICL Israel Chemicals has a Current Valuation of 43.75 B. This is 283.48% higher than that of the Chemicals sector and significantly higher than that of the Materials industry. The current valuation for all Israel stocks is 163.18% lower than that of the firm.
ICL Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ICL Israel's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ICL Israel could also be used in its relative valuation, which is a method of valuing ICL Israel by comparing valuation metrics of similar companies.ICL Israel is currently under evaluation in current valuation category among its peers.
ICL Fundamentals
| Return On Equity | 0.43 | |||
| Return On Asset | 0.19 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.34 % | |||
| Current Valuation | 43.75 B | |||
| Shares Outstanding | 1.29 B | |||
| Shares Owned By Insiders | 44.90 % | |||
| Shares Owned By Institutions | 25.12 % | |||
| Price To Book | 2.00 X | |||
| Price To Sales | 3.31 X | |||
| Revenue | 6.96 B | |||
| Gross Profit | 2.61 B | |||
| EBITDA | 1.8 B | |||
| Net Income | 783 M | |||
| Cash And Equivalents | 492 M | |||
| Cash Per Share | 0.38 X | |||
| Total Debt | 2.44 B | |||
| Debt To Equity | 0.67 % | |||
| Current Ratio | 1.52 X | |||
| Book Value Per Share | 4.12 X | |||
| Cash Flow From Operations | 1.06 B | |||
| Earnings Per Share | 5.67 X | |||
| Price To Earnings To Growth | 168.10 X | |||
| Target Price | 9.13 | |||
| Number Of Employees | 12.5 K | |||
| Beta | 0.41 | |||
| Market Capitalization | 34.72 B | |||
| Total Asset | 11.08 B | |||
| Retained Earnings | 2.5 B | |||
| Working Capital | 939 M | |||
| Current Asset | 2.98 B | |||
| Current Liabilities | 2.05 B | |||
| Z Score | 8.4 | |||
| Annual Yield | 0.12 % | |||
| Five Year Return | 3.53 % | |||
| Net Asset | 11.08 B | |||
| Last Dividend Paid | 0.9 |
About ICL Israel Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ICL Israel Chemicals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ICL Israel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ICL Israel Chemicals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in ICL Stock
When determining whether ICL Israel Chemicals is a strong investment it is important to analyze ICL Israel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ICL Israel's future performance. For an informed investment choice regarding ICL Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.